Compare PGIM India Healthcare Fund vs ICICI Prudential Pharma Healthcare and Diagnostics (P.H.D) Fund
PGIM India Healthcare Fund
ICICI Prudential Pharma Healthcare and Diagnostics (P.H.D) Fund
Risk
Very High
Very High
Rating
-
5.0
Min SIP Amount
₹1000
₹100
Expense Ratio
2.58
2.09
NAV
₹12.24
₹47.50
Fund Started
19 Nov 2024
25 Jun 2018
Fund Size
₹103.24 Cr
₹6624.58 Cr
Exit Load
Exit load of 0.50%, if redeemed within 90 days.
Exit load of 1% if redeemed within 15 days.
1 Year
16.55%
5.43%
3 Year
-
23.11%
5 Year
-
15.81%
Equity
96.90%
96.05%
Cash
-0.09%
3.95%
Top 10 Holdings
Sun Pharmaceutical Industries Ltd. | 10.86% |
Divi's Laboratories Ltd. | 9.14% |
Max Healthcare Institute Ltd. | 6.52% |
Aster DM Healthcare Ltd. | 6.41% |
JB Chemicals & Pharmaceuticals Ltd. | 6.40% |
Ajanta Pharma Ltd. | 5.56% |
Mankind Pharma Ltd. | 5.19% |
Krishna Institute of Medical Sciences Ltd | 4.12% |
Rubicon Research Ltd. | 3.99% |
Neuland Laboratories Ltd. | 3.19% |
Sun Pharmaceutical Industries Ltd. | 12.20% |
Dr. Reddy's Laboratories Ltd. | 8.22% |
Mankind Pharma Ltd. | 6.98% |
Cipla Ltd. | 6.67% |
Alkem Laboratories Ltd. | 5.67% |
Divi's Laboratories Ltd. | 5.57% |
Cohance Lifesciences Ltd. | 4.31% |
Medplus Health Services Ltd. | 3.66% |
Max Healthcare Institute Ltd. | 3.10% |
Syngene International Ltd. | 2.89% |
Name
-
-
Start Date
-
-
Description
The scheme seek to generate consistent returns by predominantly investing in equity and equity related securities of pharmaceutical and healthcare companies.
The scheme seeks to generate long-term capital appreciation by creating a portfolio that is invested in equity and equity related securities of pharma, healthcare, hospitals, diagnostics, wellness and allied companies.
Launch Date
19 Nov 2024
25 Jun 2018
